SCHEMBL18166580

SCHEMBL18166580

Cn1c(=O)c2c(ncn2CC(=O)Nc2nc(-c3ccc(Cl)c(Cl)c3)c(-c3ccccc3)s2)n(C)c1=O

nearest known ligand 0.58

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 1/20 0.58
▸ SMN1; SMN2 Q16637 2/20 0.58
▸ LMNA P02545 1/20 0.58
▸ KMT2A Q03164 1/20 0.56
▸ RXFP1 Q9HBX9 4/20 0.55
▸ TP53 P04637 1/20 0.55
▸ POLB P06746 1/20 0.54
▸ PORCN Q9H237 1/20 0.54
▸ MAPT P10636 2/20 0.54
▸ KDM4E B2RXH2 1/20 0.53
▸ TSHR P16473 1/20 0.53
▸ ATM Q13315 1/20 0.53
▸ THRB P10828 1/20 0.53
▸ CYP1A2 P05177 1/20 0.53
▸ TRPA1 O75762 1/20 0.51
▸ ALOX15 P16050 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ NPSR1 Q6W5P4 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18166686 0.95 KMT2A (0.60) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166668 0.91 HSD17B10 (0.64) HSD17B10SMN1; SMN2LMNARXFP1TP53
SCHEMBL18166650 0.91 KDM4E (0.65) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166734 0.91 LMNA (0.59) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166585 0.89 KMT2A (0.60) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166713 0.89 MAPT (0.60) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166568 0.88 KDM4E (0.65) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL15075685 0.87 KDM4E (0.58) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166720 0.87 KMT2A (0.58) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1
SCHEMBL18166605 0.86 TRPA1 (0.59) HSD17B10SMN1; SMN2LMNAKMT2ARXFP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3663295-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL ELI LILLY AND CO. (US) 2020-06-10 — — EP disclosed
EP-3184527-A1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL Hydra Biosciences, Inc. (US) 2017-06-28 — — EP disclosed
EP-2170309-B1 2,6-DIOXO,-2,3-DIHYDRO-1H-PURINE COMPOUNDS USEFUL FOR TREATING DISORDERS RELATED TO THE ACTIVITY OF THE TRPA1 CHANNEL HYDRA BIOSCIENCES INC (US) 2016-10-26 — — EP disclosed
Send feedback